medigraphic.com

2015, Number 5

<< Back Next >>

Rev Med Inst Mex Seguro Soc 2015; 53 (5)

Subconjunctival chemotherapy in patients with acquired immunodefi ciency syndrome. Experimental study of 3 clinical cases

Melgares-Ramos MÁ, Carnesoltas-Lázaro D, Silveira-Melgares YS, Domínguez-Odio A

Language: Spanish
References: 20
Page: 564-568
PDF size: 226.70 Kb.


ABSTRACT

Background: Squamous carcinoma of conjuctive (SCC) is a rare tumour with different geographic frequency. The ethiology is multifactorial, and included high exposition to UV and also systematic infections (HPV and HIV). Those tumours have low potential of malignity, but occasionally this type of cancer is capable to provoke local recidive and distant metastasis and fi nally the death of patients. The aim of this work was to investigate the antitumoral response, the tolerable and safe doses of cysplatin preparation in three patients with HIV with recurrent SCC by subconjuctival and topical administration after conservative surgery.
Methods: The patients were treated with cysplatin preparation. The treatment was about 3 months in 6 cycles. The patients were clinical follow since the last administration until update.
Results: The evolution was favorable. The patients preserved the eyes and their vision without SCC recidive. One patient died about 2 years after he fi nalized the treatment with conservative vision and without tumoral activity and the cause was HIV infection.
Conclusion: Treatment with adjuvant chemotherapy to surgery subconjunctival is effective and tolerable in the population of patients treated.


REFERENCES

  1. Mittal R, Rath S, Vemuganti GK. Ocular surface squamous neoplasia - Review of etio-pathogenesis and an update on clinico-pathological diagnosis. Saudi J Ophthalmol. 2013; 27(3):177-86.

  2. Emmanuel B, Ruder E, Lin S-W, Abnet C, Hollenbeck AR, Mbulaiteye SM. Incidence of squamouscell carcinoma of the conjunctiva and other eye cancers in the NIH-AARP Diet and Health Study. Cancer Medical Science . 2012; 6: 54-261.

  3. RNC. Registro Nacional del Cáncer. 2011. http://fi les. sld.cu/bvscuba/fi les/2012/05/anuario-2011-e.pdf

  4. Melgares MA, Mesa E, Puig M. Resultados del tratamiento del carcinoma epidermoide de conjuntiva, estudio a largo plazo. Rev Cub Oncol. 2001;17(3): 195-9.

  5. Mwololo A, Nyagol J, Rogena E, Ochuk W, Kimani M, et al. Correlation of EGFR, pEGFR and p16INK4 expressions and high risk HPV infection in HIV/ AIDS-related squamous cell carcinoma of conjunctiva. Infect Agent Cancer. 2014 Feb 26;9(1):7.

  6. Carreira H, Coutinho F, Carrilho C, Lunet N. HIV and HPV infections and ocular surface squamous neoplasia: systematic review and meta-analysis. Br J Cancer. 2013 1;109(7):1981-8.

  7. Shields CL, Ramasubramanian A, Mellen PL, Shields JA. Conjunctival squamous cell carcinoma arising in immunosuppressed patients (organ transplant, human immunodefi ciency virus infection). Ophthalmology. 2011;118(11):2133-2137.

  8. Ateenyi-Agaba C, Dai M, Le Calvez F, Katongole- Mbidde E, Smet A, et al. TP53 mutations in squa mous-cell carcinomas of the conjunctiva: evidence for UV-induced mutagenesis. Mutagenesis. 2004; 19(5):399-401.

  9. Crim N, Forniés-Paz ME, Monti R, Espósito E, Maccio JP, Urrets-Zavalía JA. In situ carcinoma of the conjunctiva: surgical excision associated with cryotherapy. Clin Ophthalmol. 2013;7:1889-93.

  10. Walsh-Conway N, Conway RM. Plaque brachytherapy for the management of ocular surface malignancies with corneoscleral invasion. Clin Experiment Ophthalmol. 2009;37(6):577-83.

  11. Al-Barrag A, Al-Shaer M, Al-Matary N, Al-Hamdani M. 5-Fluorouracil for the treatment of intraepithelial neoplasia and squamous cell carcinoma of the conjunctiva, and cornea. Clin Ophthalmol. 2010 Jul 30; 4:801-8.

  12. Melgares Ramos MA, Ríos Hernández M, Cepero J, Figueroa J, Hugues JC. Estudio de la toxicidad aguda del cisplatino administrado por vía subconjuntival en conejos. Posible tratamiento para los tumores epiteliales de la conjuntiva. Rev Visión Pan-Americana .Vol V(4). 2006;16-17.

  13. Maudgil A, Patel T, Rundle P, Rennie IG, Mudhar HS. Ocular surface squamous neoplasia: analysis of 78 cases from a UK ocular oncology centre. Br J Ophthalmol. 2013 Dec;97(12):1520-4.

  14. Kim BH, Kim MK, Wee WR, Oh JY. Clinical and pathological characteristics of ocular surface squamous neoplasia in an Asian population. Graefes Arch Clin Exp Ophthalmol. 2013;251(11):2569-73.

  15. Pola EC, Masanganise R, Rusakaniko S. The trend of ocular surface squamous neoplasia among ocular surface tumour biopsies submitted for histology from Sekuru Kaguvi Eye Unit, Harare between 1996 and 2000. Centr Afr J. of Med. 2003;49:1-4.

  16. Gichuhi S, Sagoo MS, Weiss HA, Burton MJ. Epidemiology of ocular surface squamous neoplasia in Africa. Trop Med Int Health. 2013 Dec;18(12):1424-43.

  17. Gichuhi S, Irlam JJ. Interventions for squamous cell carcinoma of the conjunctiva in HIV-infected individuals Cochrane Database Syst Rev. 2007 Apr 18;(2):23- 27. Update: Cochrane Database Syst Rev. 2013.

  18. González Yglesias Y, García Álvarez H, Ríos Araujo B, Suárez Rodríguez B. Carcinoma epidermoide de conjuntiva: Presentación de un caso. MediSur, vol. 4 (1), 2006, 99-102.

  19. Finger PT, Chin KJ. Refractory squamous cell carcinoma of the conjunctiva treated with subconjunctival ranibizumab (Lucentis): a two-year study. Ophthal Plast Reconstr Surg 2012;28(2):85-9.

  20. Formulario Nacional de Medicamentos. 2013. http:// fnmedicamentos.sld.cu/index.php?P=Home




2020     |     www.medigraphic.com